Newsfeed

Progress made in understanding Pulmonary Arterial Hypertension
July 17, 2013 Source: News Medical The next step has been made into isolating the origin of cells linked to the progressive disorder Pulmonary Arterial Hypertension. Further strides have been made into isolating the origin of cells that could lead to a greater understanding of what goes into the development of our blood circulating systems. University of Lincoln Life Sciences academic Dr Rajiv Machado, with colleagues from the Univers…
Heart failure: New treatment option makes heart 'softer'
July 12, 2013 Source: Medical Xpress Heart failure with concomitant pulmonary hypertension is a growing health problem with a high mortality rate, above all in older people. The cardiologist Diana Bonderman from the University Department of Internal Medicine II at the MedUni Vienna, as the author of a multinational phase II study, has demonstrated the effectiveness of a substance that sticks to the so-called nitric oxide pathway and makes th…
Pulmonary Denervation Shows Promise for Resistant Pulmonary Hypertension
July 16, 2013 Source: TCTMD Key Points: Pilot study tests pulmonary artery denervation for idiopathic pulmonary hypertension Treatment reduces pulmonary pressure, increases functional capacity at 3 months Procedure could open new avenue for patients with few options, outside experts say By Yael L. Maxwell Tuesday, July 16, 2013 A novel pulmonary artery denervation approach is safe and effective for patients with idiopathic pulmona…
Gender, sex hormones and pulmonary hypertension
July 8, 2013 Source: Pulmonary Circulation - Official Journal of the Pulmonary Vascular Research Institute Abstract: Most subtypes of pulmonary arterial hypertension (PAH) are characterized by a greater susceptibility to disease among females, although females with PAH appear to live longer after diagnosis. While this "estrogen paradox" of enhanced female survival despite increased female susceptibility remains a mystery, recent progress ha…
Rare illness makes life a struggle
July 6, 2013 Jenna Lowe was a dancer and a swimmer, but now she uses a mobility scooter to get to her matric classes at Herschel, and can’t walk any distance without becoming dizzy and weak. Every day, the 18-year-old Claremont girl breathes oxygen through a tube, swallows warfarin to prevent her blood from clotting and takes imitation Viagra designed to dilate the vessels in her lungs. But it’s bosentan that will help prolong her life. …
New progress in pulmonary hypertension research
July 16, 2013 Source: Doctor Tipster Researchers at the University of Lincoln in colaboration with those from the University of Cambridge, King’s College London and Papworth Hospital, made new advances in the research regarding pulmonary hypertension. They were able to isolate the cells associated with the disease: blood outgrowth endothelial cells (BOEC). Pulmonary hypertension is defined by a pressure greater than 25 mmHg in the pulmonary …
Singing opera with someone else's lungs
Source: Washington Post By Maggie Fazeli Fard, Published: May 27 Growing up in a family of 11 children, Charity Tillemann-Dick accumulated what she calls “a lovely collection of scars”: pinched skin from the time one of her brothers accidentally twisted her right arm in a playground swing; a teenage shaving nick on her right shin; a pockmark, also on her right leg, from tripping in a pothole in Russia. But the masterpiece of her collection i…
Annual pulmonary hypertension screening recommended for systemic sclerosis
By: MITCHEL L. ZOLER, Internal Medicine News Digital Network MADRID – Patients with systemic sclerosis should undergo annual screening for pulmonary arterial hypertension using a combination of transthoracic echocardiography and pulmonary function tests, an international expert panel said. These are the first evidence- and consensus-based recommendations for pulmonary arterial hypertension (PAH) screening in patients with systemic sclerosis, …
Oestrogen and the sexual dimorphism of pulmonary arterial hypertension: a translational challenge
Source: European Respiratory Journal Jessica K. Paulus*,# and Kari E. Roberts¶⇑ *Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA #Dept of Epidemiology, Harvard School of Public Health, Boston, MA ¶Dept of Medicine, Tufts Medical Center, Boston, MA, USA K.E. Roberts, Tufts Medical Center, Dept of Medicine, Pulmonary, Critical Care and Sleep Division, 800 Washington Street, #257, Boston, MA 02111, USA. E-ma…
Riociguat Shows Promise in Pulmonary Hypertension
Source: American Thoracic Society By Ed Susman, Contributing Writer, MedPage Today Published: May 22, 2013 Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner PHILADELPHIA -- The investigative agent riociguat increased distance walked by patients diagnosed with pulmonary arterial hypertension, researchers reported here. In patients…
Recent News

Subscribe

Get the latest on PH treatments, community events and more when you subscribe to our newsletter

ImagineCan_Accreditation_Trustmark_ENGFR_WHT-FNL_white.png